[go: up one dir, main page]

GB201706404D0 - Method of treatment - Google Patents

Method of treatment

Info

Publication number
GB201706404D0
GB201706404D0 GBGB1706404.9A GB201706404A GB201706404D0 GB 201706404 D0 GB201706404 D0 GB 201706404D0 GB 201706404 A GB201706404 A GB 201706404A GB 201706404 D0 GB201706404 D0 GB 201706404D0
Authority
GB
United Kingdom
Prior art keywords
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1706404.9A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Volution Immuno Pharmaceuticals SA
Original Assignee
Volution Immuno Pharmaceuticals SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Volution Immuno Pharmaceuticals SA filed Critical Volution Immuno Pharmaceuticals SA
Priority to GBGB1706404.9A priority Critical patent/GB201706404D0/en
Publication of GB201706404D0 publication Critical patent/GB201706404D0/en
Priority to US16/603,352 priority patent/US11730792B2/en
Priority to EP23166056.4A priority patent/EP4275696A1/en
Priority to PL18726731.5T priority patent/PL3612208T3/en
Priority to ES18726731T priority patent/ES2945433T3/en
Priority to CN201880041710.5A priority patent/CN110896606B/en
Priority to DK18726731.5T priority patent/DK3612208T5/en
Priority to KR1020197031711A priority patent/KR102656199B1/en
Priority to EP18726731.5A priority patent/EP3612208B1/en
Priority to JP2019556794A priority patent/JP7209637B2/en
Priority to IL269895A priority patent/IL269895B2/en
Priority to CA3059657A priority patent/CA3059657A1/en
Priority to PCT/EP2018/060241 priority patent/WO2018193122A1/en
Priority to AU2018253962A priority patent/AU2018253962B2/en
Priority to JP2023001554A priority patent/JP7600278B2/en
Priority to US18/332,191 priority patent/US20240009270A1/en
Ceased legal-status Critical Current

Links

GBGB1706404.9A 2017-04-21 2017-04-21 Method of treatment Ceased GB201706404D0 (en)

Priority Applications (16)

Application Number Priority Date Filing Date Title
GBGB1706404.9A GB201706404D0 (en) 2017-04-21 2017-04-21 Method of treatment
AU2018253962A AU2018253962B2 (en) 2017-04-21 2018-04-20 Coversin for the treatment of autoimmune blistering diseases
DK18726731.5T DK3612208T5 (en) 2017-04-21 2018-04-20 COVERSIN FOR THE TREATMENT OF AUTOIMMUNE DISEASES WITH BLISTER FORMATION
EP18726731.5A EP3612208B1 (en) 2017-04-21 2018-04-20 Coversin for the treatment of autoimmune blistering diseases
PL18726731.5T PL3612208T3 (en) 2017-04-21 2018-04-20 Coversin for the treatment of autoimmune blistering diseases
ES18726731T ES2945433T3 (en) 2017-04-21 2018-04-20 Coversin for the treatment of autoimmune blistering diseases
CN201880041710.5A CN110896606B (en) 2017-04-21 2018-04-20 COVERSIN for the treatment of autoimmune vesicular disease
US16/603,352 US11730792B2 (en) 2017-04-21 2018-04-20 Coversin (OmCI) for the treatment of autoimmune blistering diseases: bullous pemphigoid (BP) and epidermolysis bullosa acquisita (EBA)
KR1020197031711A KR102656199B1 (en) 2017-04-21 2018-04-20 Coversin for the treatment of autoimmune blistering disease
EP23166056.4A EP4275696A1 (en) 2017-04-21 2018-04-20 Coversin for the treatment of autoimmune blistering diseases
JP2019556794A JP7209637B2 (en) 2017-04-21 2018-04-20 Covacine for the treatment of autoimmune bullous disease
IL269895A IL269895B2 (en) 2017-04-21 2018-04-20 Coversin for the treatment of autoimmune blistering diseases
CA3059657A CA3059657A1 (en) 2017-04-21 2018-04-20 Coversin for the treatment of autoimmune blistering diseases
PCT/EP2018/060241 WO2018193122A1 (en) 2017-04-21 2018-04-20 Coversin for the treatment of autoimmune blistering diseases
JP2023001554A JP7600278B2 (en) 2017-04-21 2023-01-10 Covarcin for the treatment of autoimmune bullous diseases
US18/332,191 US20240009270A1 (en) 2017-04-21 2023-06-09 Coversin for the treatment of autoimmune blistering diseases

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1706404.9A GB201706404D0 (en) 2017-04-21 2017-04-21 Method of treatment

Publications (1)

Publication Number Publication Date
GB201706404D0 true GB201706404D0 (en) 2017-06-07

Family

ID=58795810

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1706404.9A Ceased GB201706404D0 (en) 2017-04-21 2017-04-21 Method of treatment

Country Status (1)

Country Link
GB (1) GB201706404D0 (en)

Similar Documents

Publication Publication Date Title
ZA202006746B (en) Methods of treatment
ZA201706059B (en) Method of treatment with tradipitant
GB2567616B (en) Treatment method
EP3684342C0 (en) Method of treatment
GB201410116D0 (en) Method of treatment
GB201815588D0 (en) Method of treatment
ZA201705877B (en) Method of treating diseases
ZA201908539B (en) Method of treatment of cancer
GB201706406D0 (en) Method of treatment
IL253028B (en) Method of treatment
GB2571601B (en) Treatment method
SG11202001806TA (en) Treatment method
SG11202005850VA (en) Methods of treatment of hypertrigl yceridemia
GB201602802D0 (en) Method of treatment
SG11202105877YA (en) Method of treatment
GB201512139D0 (en) Methods of treatment
GB201720439D0 (en) Method of treatment
GB201718589D0 (en) Method of treatment
GB201709554D0 (en) Method of treatment
GB201706642D0 (en) Method of treatment
GB201706452D0 (en) Method of treatment
GB201706404D0 (en) Method of treatment
GB201706398D0 (en) Method of treatment
GB201820236D0 (en) Method of treatment
GB201820157D0 (en) Method of treatment

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)